SYRA · Syra Health Corp
Market Cap
$10.79M
Shares
13.84M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.06
Open$0.07
Day$0.03–0.12
52W close$0.06–2.14
Avg vol 30d886K
Short int312K · 2.3% float · 8.5d
Short vol54%
Last earningsMay 8, 2025
DataSep 2023–Apr 2025
Filing10-Q · Aug 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−91%
below
Price vs 50-day avg
−83%
below
RSI (14)
20
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−83%
trailing
6-month return
−86%
trailing
YTD return
−87%
this year
Relative strength
−75%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-80% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.26% of float · ▲ +103.7% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 2-yr low, contrarian setup
Fundamentals
Revenue growth
−9%
Y/Y
Gross margin
34%
expanding
EPS growth
+84%
Y/Y
Free cash flow
$-447.9K
Quant / Vol
risk profile
Volatility
152%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
88.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−91%
Bearish
Price vs 50-day avg
−83%
Bearish
RSI (14)
20
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-80% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.26% of float · ▲ +103.7% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $2
vs 200-day avg -91%
vs 50-day avg -83%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SYRA
this stock
Syra Health Corp
|
$10.79M | — | -9.5% | 78.0 | 2.3% |
|
HCA
HCA Healthcare, Inc.
|
$91.98B | -11.2% | +7.1% | 14.3 | 2.8% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.36B | -8.0% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.48B | +33.8% | +0.9% | 10.3 | 3.1% |
|
FMS
Fresenius Medical Care AG
|
$12.11B | -4.5% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
2
- % held
- 1.2%
- Net QoQ
- +3.9K sh
- Top holder
- JANE STREET GROUP, LLC
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SYRA | -72.6% | -83.1% | -86.4% | -78.9% | -86.7% |
| SPY | -3.8% | -8.9% | -11.3% | -8.1% | -12.3% |
| vs SPY | -68.9% | -74.2% | -75.1% | -70.7% | -74.3% |